Fabian cancer biology slide 41-80 Flashcards
What drug can impact the targeting of BCR/ABL?
What does this drug do?
Where does the drug fit?
-imatinib (Gleevac)
-it prevents tyrosine kinase to activate the BCR-Abl protein which can prevent chronic myelogenous leukemia
-it fits into the ATP binding pocket which prevents activation
What does imatinib do to prevent Bcr-Abl activation?
What does it prevent, what does this lead to
-imatinib binds to the bcr-abl pocket, competitively binds to site and inhibits the protein
-this prevents downstream binding and the substrate cannot enter kinase site, so the tumor cannot proliferate
What is another cellular oncogene
-erbb2/HER2
What type of signaling molcule is erbB2?
What does it respond do?
What is it also known as?
-Receptor Tyrosine Kinase.
* Responds to epidermal growth factor.
-aka neuro/glioblastoma derived oncogene homolog (neu)
* Aka human epidermal growth
factor receptor 2 (HER2).
What activates erbB2?
What can it cause when activated?
Dimerization activates proliferation and survival gene expression signaling pathways
-can cause signal transduction cascades when activated, on growth/proliferaiton and survival paths
What is an RTK example (receptor tyrosine kinase)?
where does the ectodomain protrude into?
RTKs (e.g. epidermal growth factor receptor, EGFR).
* Ectodomain protrudes in extracellular space to recognize and bind ligand.
WHere does the hydrophobic domain of RTK thread through?
Where does kinase domain sit?
- Hydrophobic transmembrane domain threads through plasma membrane lipid bilayer.
- Kinase domain sits inside cell.
What leads to RTK dimerization?
What can mutations result in?
- Hydrophobic transmembrane domain threads through plasma membrane lipid bilayer.
- Kinase domain sits inside cell.
What can RTK overexpression cause?
What type of tumor can overespression lead to?
-RTK overexpression (e.g. ERBB2) may cause cell to become hyper-responsive to low growth factor concentrations and/or cause ligand-independent RTK dimerization due to mass action effect.
-leads to 30% of breat adenocarcinomas
What does amplification of erbB2 signaling cause/
-amplification decreases survival rate by alot
What method can we use to asses gene copy number?
What should we normally see when doing FISH analysis?
WHat about when we have ERBB2 amplification?
-by using fluorescense in situ hybridization (FISH)
-we should see 2 copies of chromosome per cell?
-there are many copies in the cell, which is sign of breat carcinoma
What can we use for analysis of ERBB2/HER2+ in breast cancer cells?
What does antibody bind to get staining?
How can we see the different stages of amplification of Her2 with IHC?
-we use immunohistochemistry (IHC) to visualize
-antibody bind to HER2 then secondary antibody binds on top to get staining
-the staining will appear alot more dark
What does trazuzumab (herceptin) do?
When should this drug be given?
What is this an example of?
-binds to an extracellular domain of this receptor and inhibits HER2
homodimerization, thereby preventing HER2-mediated signaling
-should only be givent patients with ErbB2 amplification
-a personalize medical approach, typically given to breat cancer patients
What is the 3rd type of cellular oncogene?
Ras
What are the 3 types of Ras?
What type of protein is Ras, when is it active?
What can lead to Ras only being active and not turning off?
Three Ras genes (K-Ras, H-Ras, N-Ras).
* Is a GTP (G) protein that is
activated when bound to GTP.
-point mutation change single amino acids which can only lead to Ras activation
How does ras use its GTPase function?
How does it turn itself on/off?
It then uses it’s GTPase function to hydrolyze (cleave) GTP to GDP thereby inactivating itself.
Turns itself on and off like a light
What can Ras regulate?
What activates and inactivates Ras?
it can regulate growth, survival and proliferation
-GAP inactivates Ras into its GDP form
-GEF activates Ras into its GTP form
What is the most highly mutated gene in cancer?
What turns Ras from a protooncogen to an oncogene?
What type of feedback does the oncogene inactivate
-ras, the mutation is typically missense (causing point mutations along the way)
-Missense mutations in G12 and 61 turn Ras from a proto-oncogene into an oncogene.
* Lead to GTPase negative-feedback mechanism being
inactivated
What type of cancers are Ras mutations found in, what are some mutated Ras genes?
what causes this?
-Mutated RAS genes (KRAS, HRAS, NRAS) are found in many cancers, in particular 50% of colorectal cancers and 95% of pancreatic cancers
-Ras point mutation
What do proto oncogene function to regulate?
What do alterations that upregulate their expression lead to?
What do oncogenes drive?
Proto-oncogenes function to regulate normal cell proliferation and differentiation.
-Alterations that upregulate their expression or mutations that alter their structure can lead to overly active growth-promoting genes, which appear in cancer cells as activated oncogenes